A Phase 2 Proof-of-Concept clinical trial to quantify myocardial manganese uptake rate by cardiovascular magnetic resonance imaging following mangafodipir trisodium administration in healthy volunteers and heart failure patients with preserved ejection fraction caused by hypertrophic cardiomyopathy or cardiac amyloidosis.
CompletedCTIS2023-508118-40-01
IC Targets ASHeart Failure
Start: 2024-11-22End: 2025-11-29Target: 42Updated: 2025-12-16